Histological features of precancerous and early cancerous lesions of biliary tract carcinoma

Journal of Hepato-Biliary-Pancreatic Sciences

Volumn 21, Issue 7, 2014, Pages 448-452

  Aishima, Shinichi ^a   Kubo, Yuichiro ^a   Tanaka, Yuki ^a   Oda, Yoshinao ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

BilIN; Cholangiocarcinoma; Hepatolithiasis; IPNB; PSC

Indexed keywords

REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE;

ARTICLE; BILE DUCT CARCINOMA; BILE DUCT STONE; BILIARY INTRAEPITHELIAL NEOPLASM; CARCINOGENESIS; CHRONIC INFLAMMATION; COMMON BILE DUCT CYST; DNA DAMAGE; EARLY CANCER; FASCIOLIASIS; HEPATITIS B VIRUS; HISTOLOGY; HUMAN; INTRADUCTAL PAPILLARY NEOPLASM; PRECANCER; PRIMARY SCLEROSING CHOLANGITIS; RISK FACTOR; BILE DUCT TUMOR; BILIARY TRACT TUMOR; DISEASE COURSE; HEPATIC DUCT; INTRAHEPATIC BILE DUCT; PAGET NIPPLE DISEASE; PATHOLOGY;

BILE DUCT NEOPLASMS; BILE DUCTS, EXTRAHEPATIC; BILE DUCTS, INTRAHEPATIC; BILIARY TRACT NEOPLASMS; CARCINOMA, DUCTAL; CHOLANGIOCARCINOMA; DISEASE PROGRESSION; HUMANS; PRECANCEROUS CONDITIONS;

EID: 84902673918     PISSN: 18686974     EISSN: 18686982     Source Type: Journal    
DOI: 10.1002/jhbp.71     Document Type: Article

References (37)

1. Japanese Society of Biliary Surgery. General rules for surgical and pathological studies on cancer of the biliary tract, 5th edn. Tokyo: Kanehara; 2003.
2. Edge SB, editor. Intrahpetic bile ducts. AJCC Cancer Staging Manual, 7th edn. New York: Springer; 2009. p. 201-234.
3. Klatskin G,. Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatis. An unusual tumor with distinctive clinical and pathological features. Am J Med. 1965; 38: 241-256.
4. Okuda K, Kubo Y, Okazaki N, Arishima T, Hashimoto M,. Clinical aspects of intrahepatic bile duct carcinoma including hilar carcinoma: a study of 57 autopsy-proven cases. Cancer. 1977; 39: 232-246.
5. Aishima S, Kuroda Y, Nishihara Y, Iguchi T, Taguchi K, Taketomi A, et al. Proposal of progression model for intrahepatic cholangiocarcinoma: clinicopathologic differences between hilar type and peripheral type. Am J Surg Pathol. 2007; 31: 1059-1067.
6. Tyson GL, El-Serag HB,. Risk factors for cholangiocarcinoma. Hepatology. 2011; 54: 173-184.
7. Burak K, Angulo P, Pasha TM, Egan K, Petz J, Lindor KD,. Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis. Am J Gastroenterol. 2004; 99: 523-526.
8. Bergquist A, Ekbom A, Olsson R, Kornfeldt D, Loof L, Danielsson A, et al. Hepatic and extrahepatic malignancies in primary sclerosing cholangitis. J Hepatol. 2002; 36: 321-327.
9. Tsui WM, Lam PW, Lee WK, Chan YK,. Primary hepatolithiasis, recurrent pyogenic cholangitis, and oriental cholangiohepatitis: a tale of 3 countries. Adv Anat Pathol. 2011; 18: 318-328.
10. El-Serag HB, Engels EA, Landgren O, Chiao E, Henderson L, Amaratunge HC, et al. Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: a population based study of U.S. veterans. Hepatology. 2009; 49: 116-123.
11. Lee TY, Lee SS, Jung SW, Jeon SH, Yun SC, Oh HC, et al. Hepatitis B virus infection and intrahepatic cholangiocarcinoma in Korea: a case-control study. Am J Gastroenterol. 2008; 103: 1716-1720.
12. Zen Y, Adsay NV, Bardadin K, Colombari R, Ferrell L, Haga H, et al. Biliary intraepithelial neoplasia: an international interobserver agreement study and proposal for diagnostic criteria. Mod Pathol. 2007; 20: 701-709.
13. Nakanuma Y, Sasaki M, Sato Y, Ren X, Ikeda H, Harada K,. Multistep carcinogenesis of perihilar cholangiocarcinoma arising in the intrahepatic large bile ducts. World J Hepatol. 2009; 1: 35-42.
14. Adsay V, Jang KT, Roa JC, Dursun N, Ohike N, Bagci P, et al. Intracholecystic papillary-tubular neoplasms (ICPN) of the gallbladder (neoplastic polyps, adenomas, and papillary neoplasms that are ≥1.0 cm): clinicopathologic and immunohistochemical analysis of 123 cases. Am J Surg Pathol. 2012; 36: 1279-1301.
15. Ohike N, Kim GE, Tajiri T, Krasinskas A, Basturk O, Coban I, et al. Intra-ampullary papillary-tubular neoplasm (IAPN): characterization of tumoral intraepithelial neoplasia occurring within the ampulla: a clinicopathologic analysis of 82 cases. Am J Surg Pathol. 2010; 34: 1731-1748.
16. Davis RI, Sloan JM, Hood JM, Maxwell P,. Carcinoma of the extrahepatic biliary tract: a clinicopathological and immunohistochemical study. Histopathology. 1988; 12: 623-631.
17. Suzuki M, Takahashi T, Ouchi K, Matsuno S,. The development and extension of hepatohilar bile duct carcinoma. A three-dimensional tumor mapping in the intrahepatic biliary tree visualized with the aid of a graphics computer system. Cancer. 1989; 64: 658-666.
18. Lewis JT, Talwalkar JA, Rosen CB, Smyrk TC, Abraham SC,. Precancerous bile duct pathology in end-stage primary sclerosing cholangitis, with and without cholangiocarcinoma. Am J Surg Pathol. 2010; 34: 27-34.
19. Zen Y, Sasaki M, Fujii T, Chen TC, Chen MF, Yeh TS, et al. Different expression patterns of mucin core proteins and cytokeratins during intrahepatic cholangiocarcinogenesis from biliary intraepithelial neoplasia and intraductal papillary neoplasm of the bile duct-an immunohistochemical study of 110 cases of hepatolithiasis. J Hepatol. 2006; 44: 350-358.
20. Aishima S, Iguchi T, Fujita N, Taketomi A, Maehara Y, Tsuneyoshi M, et al. Histological and immunohistological findings in biliary intraepithelial neoplasia arising from a background of chronic biliary disease compared with liver cirrhosis of non-biliary aetiology. Histopathology. 2011; 59: 867-875.
21. Aishima S, Kuroda Y, Nishihara Y, Taguchi K, Taketomi A, Maehara Y, et al. Gastric mucin phenotype defines tumour progression and prognosis of intrahepatic cholangiocarcinoma: gastric foveolar type is associated with aggressive tumour behaviour. Histopathology. 2006; 49: 35-44.
22. Hsu M, Sasaki M, Igarashi S, Sato Y, Nakanuma Y,. KRAS and GNAS mutations and p53 overexpression in biliary intraepithelial neoplasia and intrahepatic cholangiocarcinomas. Cancer. 2013; 119: 1669-1674.
23. Nakanishi Y, Zen Y, Kondo S, Itoh T, Itatsu K, Nakanuma Y,. Expression of cell cycle-related molecules in biliary premalignant lesions: biliary intraepithelial neoplasia and biliary intraductal papillary neoplasm. Hum Pathol. 2008; 39: 1153-1161.
24. Lin F, Shi J, Liu H, Hull ME, Dupree W, Prichard JW, et al. Diagnostic utility of S100P and von Hippel-Lindau gene product (pVHL) in pancreatic adenocarcinoma-with implication of their roles in early tumorigenesis. Am J Surg Pathol. 2008; 32: 78-91.
25. Aishima S, Fujita N, Mano Y, Kubo Y, Tanaka Y, Taketomi A, et al. Different roles of S100P overexpression in intrahepatic cholangiocarcinoma: carcinogenesis of perihilar type and aggressive behavior of peripheral type. Am J Surg Pathol. 2011; 35: 590-598.
26. Tsai JH, Huang WC, Kuo KT, Yuan RH, Chen YL, Jeng YM,. S100P immunostaining identifies a subset of peripheral-type intrahepatic cholangiocarcinomas with morphological and molecular features similar to those of perihilar and extrahepatic cholangiocarcinomas. Histopathology. 2012; 61: 1106-1116.
27. Kawanishi S, Hiraku Y, Pinlaor S, et al. Oxidative and nitrative DNA damage in animals and patients with inflammatory diseases in relation to inflammation-related carcinogenesis. Biol Chem. 2006; 387: 365-372.
28. Kim SF, Huri DA, Snyder SH,. Inducible nitric oxide synthase binds, S-nitrosylates, and activates cyclooxygenase-2. Science. 2005; 310: 1966-1970.
29. Endo K, Yoon BI, Pairojkul C, Demetris AJ, Sirica AE,. ERBB-2 overexpression and cyclooxygenase-2 up-regulation in human cholangiocarcinoma and risk conditions. Hepatology. 2002; 36: 439-450.
30. Aishima S, Mano Y, Tanaka Y, Kubo Y, Shirabe K, Maehara Y, et al. Different roles of inducible nitric oxide synthase and cyclooxygenase-2 in carcinogenesis and metastasis of intrahepatic cholangiocarcinoma. Hum Pathol. 2013; 44: 1031-1037.
31. Rougemont AL, Genevay M, McKee TA, Gremaud M, Mentha G, Rubbia-Brandt L,. Extensive biliary intraepithelial neoplasia (BilIN) and multifocal early intrahepatic cholangiocarcinoma in non-biliary cirrhosis. Virchows Arch. 2010; 456: 711-717.
32. Wu TT, Levy M, Correa AM, Rosen CB, Abraham SC,. Biliary intraepithelial neoplasia in patients without chronic biliary disease: analysis of liver explants with alcoholic cirrhosis, hepatitis C infection, and noncirrhotic liver diseases. Cancer. 2009; 115: 4564-4575.
33. Aishima S, Nishihara Y, Tsujita E, Taguchi K, Soejima Y, Taketomi A, et al. Biliary neoplasia with extensive intraductal spread associated with liver cirrhosis: a hitherto unreported variant of biliary intraepithelial neoplasia. Hum Pathol. 2008; 39: 939-947.
34. Jain D, Sarode VR, Abdul-Karim FW, Homer R, Robert ME,. Evidence for the neoplastic transformation of Von-Meyenburg complexes. Am J Surg Pathol. 2000; 24: 1131-1139.
35. Jain D, Ahrens W, Finkelstein S,. Molecular evidence for the neoplastic potential of hepatic Von-Meyenburg complexes. Appl Immunohistochem Mol Morphol. 2010; 18: 166-171.
36. Sekiya S, Suzuki A,. Intrahepatic cholangiocarcinoma can arise from Notch-mediated conversion of hepatocytes. J Clin Invest. 2012; 122: 3914-3918.
37. Fan B, Malato Y, Calvisi DF, Naqvi S, Razumilava N, Ribback S, et al. Cholangiocarcinomas can originate from hepatocytes in mice. J Clin Invest. 2012; 122: 2911-2915.